Covid-19 vaccination for billions across the world faces patent, intellectual property hurdle financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
New Mexico officials threw out 75 doses of Pfizer s coronavirus vaccine over concerns they became too warm during transportation
Vials were being transported from the state s Department of Health warehouse in Albuquerque to Union County General Hospital in Clayton on
Tuesday
While en route, a digital gauge showed that the storage temperature for the vaccines was too warm
Pfizer s vaccine needs to be stored in freezers or on dry ice between -94F (-70C) and -112F (-84C)
A total of 15 vials, containing 75 doses, needed to be discarded after crews weren t able to determine what the temperatures of the vaccines were
Trying to make COVID-19 vaccine as affordable as possible: Pfizer PTI
New Delhi: Global pharma major Pfizer has said its COVID-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs for their people. The pharma major also said that it is making its best endeavour to make the vaccine available worldwide.
For this pandemic period, the company’s pricing approach is based on the principle of ensuring broad access and supplies to the governments. The aim is to make it very ‘affordable’, a Pfizer spokesperson said in a statement. The company’s decision-making is not being driven by traditional cost/benefit analysis, it added.
Committed To Engaging With India, Making Covid-19 Vaccine Accessible For All: Pfizer
Pricing in a way that can help governments to ensure that there is little to no out-of-pocket costs for their populations, the company said
PTI 17 December 2020 Unsplash PTI 2020-12-17T15:58:28+05:30 Committed To Engaging With India, Making Covid-19 Vaccine Accessible For All: Pfizer outlookindia.com 2020-12-17T16:15:46+05:30
Also read
Global pharma major Pfizer has said its Covid-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs for their people, as it seeks to ensure access to the vaccine across the world.
Share this article As the coronavirus pandemic tears through rural and urban America, healthcare workers and others at-risk of catching the disease are receiving life-saving vaccines now. Meanwhile, in a new development, opposing views of vaccine policy are front and center in the U.S. paper of record. First, we turn to the pharmaceutical industry, a powerhouse interest. Thomas Cueni is the director-general of the International Federation of Pharmaceutical Manufacturers and Associations. In a recent New York Times column, he opposed halting patents, or intellectual property rights, to accelerate companies’ distribution of coronavirus vaccines. (Uncle Sam is the authority that grants patents.)